Calculating Excess Deaths in Indonesia During the Pandemic
Calculations regarding excess mortality can provide information about the burden of deaths related to the COVID-19 pandemic, including direct and indirect deaths. Excess deaths are usually defined as the difference between the number of deaths observed in a given time period and the number of deaths expected in the same time period.
Calculating Excess Deaths in Indonesia During the Pandemic
Introduction
Data is key in dealing with the pandemic. Accurate death data is useful in knowing the true scale of the outbreak so that more measurable interventions can be implemented. However, in the midst of an ongoing epidemic, calculating the number of people who have died from this disease is often not easy. Difficulties arise starting from the definition of death which is often not agreed upon and becomes political, as well as various technical issues.
Calculation of excess deaths (excess mortality) can provide information about the burden of deaths related to the COVID-19 pandemic, including direct and indirect deaths. Excess deaths are usually defined as the difference between the number of deaths observed in a given time period and the number of deaths expected in the same time period.
This visualization provides weekly estimates of excess deaths by jurisdiction where the deaths occurred. Weekly death counts are compared with historical trends to determine whether the number of deaths is significantly higher than expected.
LaporCovid-19 in collaboration with EOCRU conducted a study on excess deaths in eight cities in Indonesia, namely Jakarta, South Tangerang-Tangerang, Bandung, Yogyakarta, Semarang, Surabaya, Lombok and Makassar. A number of journalists in eight cities who were selected as fellows were involved in this study. This makes the project to calculate excess deaths due to Covid-19 the first collaboration between scientists and journalists in Indonesia.
Apart from scientific data which is currently being written for scientific journals, journalists who receive fellowships in this program also routinely write reports in their media, as a form of monitoring the handling of the pandemic in Indonesia.
Research Paper
The following is a research results document that can be read
Media Coverage
The following is a link to news media coverage for each research area regarding death data collection.
DKI Jakarta
https://focus.tempo.co/read/1439495/meragukan-data-dki-jakarta-jual-keluar-dari-zona-merah-covid-19
https://metro.tempo.co/read/1440452/ombudsman-besar-kekerasan-vaksin-covid-19-di-dki
https://metro.tempo.co/read/1384602/anies-injak-rem-darurat-rumah-sakit-kolaps-berharap-vaksin
https://metro.tempo.co/read/1367613/disdukcapil-besar-warga-tidak-laporkan-kematian-sebuah-pandemi
https://metro.tempo.co/read/1373823/mengatur-siasat-cepat-penularan-covid-19-di-klaster-perkantoran
Bandung
https://www.beritasatu.com/nasional/697969/covid19-level-okupansi-rumah-sakit-di-bandung-capai-76
https://beritasatumedia.cld.bz/SP-210127-p/12/#zoom=zhttps://beritasatumedia.cld.bz/SP-200727P
https://beritasatumedia.cld.bz/SP-201120-P/14/#zoom=z
West Nusa Tenggara
https://amp.kompas.com/regional/read/2020/07/07/19582621/bawa-pulang-kami-kuburkan-dengan-cara-kami
Yogyakarta City
https://www.gatra.com/detail/news/500974?t=1
https://tirto.id/yogyakarta-darurat-covid-19-rumah-sakit-kolaps-kematian-melonjak-f9eP
https://tirto.id/teka-Teki-source-penularan-corona-ratusan-nakes-di-yogyakarta-f3fx
Surabaya City
https://m.youtube.com/watch?v=T-bkfcmqRIM
https://m.youtube.com/watch?v=bVa1vx2BQ1w
https://m.youtube.com/watch?v=RLaC-9IXLCY
Fellowships
About ReportCovid-19
LaporCovid19 is a forum (platforms) fellow citizens to share information regarding the number of incidents related to COVID-19 around us. Approachbottom-upthroughcitizen reportingorcrowdsourcingso that every citizen can participate in conveying information about cases related to COVID-19. For more information, visit:
Website: www.laporcovid19.org ,
IG: @laporcovid19 ,
Twitter: @LaporCovid ,
FB: Citizens' Coalition to Report Covid-19
About EOCRU
The Eijkman-Oxford Clinical Research Unit (EOCRU) aims to collaboratively develop and pursue a research agenda relevant to Indonesian healthcare providers and their patients. EOCRU is committed to infectious diseases that burden preventable or treatable morbidity and mortality in Southeast Asia, including tuberculosis, malaria, and other emerging and neglected infections. EOCRU's vision is to establish an important and highly active biomedical research center of excellence, with our hosts and partners, focused on opportunities to improve the prevention, diagnosis and treatment of these endemic infections by conducting robust randomized clinical trials that can directly impact practice and improve health outcomes in Indonesia and the region.
